Global map > Innovations > North America and Caribbean > United States > Palo Alto > Gen1E Lifesciences
Gen1E Lifesciences
GEn1E’s p38 kinase inhibitor drugs treats Acute Respiratory Distress Syndrome (ARDS) - 67% of the critically ill COVID-19 patients had ARDS.
Rankings by 
National Ranking
400th
in United StatesRegional Ranking
455th
in North America and CaribbeanGlobal Ranking
1082nd
worldwide